APA citiranje

Hu, X., Zhang, L., Dong, Y., Dong, C., Jiang, J., & Gao, W. (2018). Switching from biosimilar (Basalin) to originator (Lantus) insulin glargine is effective in Chinese patients with diabetes mellitus: A retrospective chart review. F1000Res.

Citação norma Chicago

Hu, Xia, Lei Zhang, Yanhu Dong, Chao Dong, Jikang Jiang, and Weiguo Gao. "Switching From Biosimilar (Basalin) to Originator (Lantus) Insulin Glargine Is Effective in Chinese Patients With Diabetes Mellitus: A Retrospective Chart Review." F1000Res 2018.

MLA citiranje

Hu, Xia, et al. "Switching From Biosimilar (Basalin) to Originator (Lantus) Insulin Glargine Is Effective in Chinese Patients With Diabetes Mellitus: A Retrospective Chart Review." F1000Res 2018.